MedTrace Logo

Development of Non-invasive Method for Quantifying Vitamin D Levels in the Body Using Spectroscopy

NCT01770262 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-01-05

No results posted yet for this study

Summary

Lack in vitamin D reduces the absorption of calcium in the body, accelerates bone loss and may increase the risk of fractures due to osteoporosis. An algorithm that will allow immediate and non-invasive quantification of vitamin D levels will shorten the time of diagnosis, reduce lab costs and prevent hazards or discomfort to the patient associated with a blood test.

The goal of the study is therefore to develop a non-invasive method for quantifying vitamin D levels in the body using spectroscopy.

40 subjects will be recruited: 20 hospitalized patients in the rehabilitation department, diagnosed with osteoporosis and 20 healthy subjects. Spectroscopy will be used with visible light on the subject's skin and middle infrared (MIR) on the blood sample to find correlation with the chemical lab test results.

Conditions

Sponsors & Collaborators

  • Ruppin Acdemic Center

    collaborator OTHER

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Mordechi Hallak, MD, MPA · Hillel Yaffe Medical Center

  • Sigal Portnoy, PhD · Hadassah Medical Organization

  • ben zion Dekel, PhD · Rupin academic center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01770262 on ClinicalTrials.gov